{"title":"다음 뉴스 ─ 전체기사 ─ 보도자료","url":"https://news.daum.net/breakingnews/press","favicon":"https://news.daum.net/breakingnews/favicon.ico","elements":[{"title":"학교 스마트기기 고장, 경기도에선 전화 한 통으로 수리 끝","contents":"데일리안<span class=\"txt_bar\"> · </span><span class=\"info_time\">16:16</span>","link":"https://v.daum.net/v/20240602161659619","retrieved":1717316379998},{"title":"한화그룹, 맑은학교 환경운동회 개최","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">16:07</span>","link":"https://v.daum.net/v/20240602160703487","retrieved":1717312587041},{"title":"국제아로마테라피임상연구센터, 북광주농협 여성대학에서 행복한 중년기를 위한 ‘힐링 아로마 프로그램’ 진행","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">15:47</span>","link":"https://v.daum.net/v/20240602154703004","retrieved":1717312587043},{"title":"아큐타 바이오테크놀로지, ASCO 2024에서 ER+/HER2- 유방암 환자를 대상으로 한 AC699 단독요법의 제1상 데이터 발표","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">15:37</span>","link":"https://v.daum.net/v/20240602153703810","retrieved":1717312587043},{"title":"Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">15:37</span>","link":"https://v.daum.net/v/20240602153702809","retrieved":1717312587044},{"title":"Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">15:07</span>","link":"https://v.daum.net/v/20240602150707173","retrieved":1717309340007},{"title":"마베니어, 새로운 옴디아 RAN 벤더 보고서에서 상위권 차지","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">15:07</span>","link":"https://v.daum.net/v/20240602150706172","retrieved":1717309340008},{"title":"Mavenir Shines in New Omdia RAN Vendors Report","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">15:07</span>","link":"https://v.daum.net/v/20240602150705171","retrieved":1717309340010},{"title":"서울 강서구청소년상담복지센터, 지역 주민들과 청소년을 위한 무더위 쉼터 운영","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">15:07</span>","link":"https://v.daum.net/v/20240602150703169","retrieved":1717309340011},{"title":"위프로, 시스코 및 AT&T와 협력해 리테일 미디어 제품 확대","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">14:57</span>","link":"https://v.daum.net/v/20240602145703947","retrieved":1717309340012},{"title":"Wipro Expands Retail Media Offering in Collaboration with Cisco and AT&T","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">14:57</span>","link":"https://v.daum.net/v/20240602145702945","retrieved":1717309340014},{"title":"에너지 볼트-스키드모어, 오윙스 앤 메릴, 에너지 저장을 건물 설계에 통합하는 글로벌 중력 에너지 저장 독점 파트너십 발표","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">14:27</span>","link":"https://v.daum.net/v/20240602142704290","retrieved":1717309340015},{"title":"Energy Vault and Skidmore, Owings & Merrill (SOM) Announce Exclusive Global Gravity Energy Storage Partnership to Integrate Energy Storage into Building Design","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">14:27</span>","link":"https://v.daum.net/v/20240602142703289","retrieved":1717309340016},{"title":"Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">13:37</span>","link":"https://v.daum.net/v/20240602133706481","retrieved":1717305400368},{"title":"모리나가 유업, 장내 독소 전구체 대사에서 인체 유래 비피더스균 균주의 우수성을 뒷받침하는 획기적 신규 연구 결과 발표","contents":"뉴스와이어<span class=\"txt_bar\"> · </span><span class=\"info_time\">13:37</span>","link":"https://v.daum.net/v/20240602133705480","retrieved":1717305400369}]}